Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. abt

ABT

AXVIRIUM BIOACTIVE TECNOLOGY_ The first medical device able to eliminate the fluids biological hazard

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 ABT project word cloud

Explore the words cloud of the ABT project. It provides you a very rough idea of what is the project "ABT" about.

estimate    survey    direct    annually    valuation    healthcare    fluid    impacts    ip    almost    anticipated    infectious    natural    8    adantium    axivirium    hiv    imply    device    ing    21    23    identification    feasibility    global    hepatitis    biological    million    abt    18    saving    segments    biomedical    14    health    accidents    efficiency    hire    market    molecules    industry    diseases    39    employees    proper    infection    2018    2022    validate    day    organisation    fluids    tecnology    tons    community    validation    hazardous    virus    rnases    commercial    barriers    posing    environment    disposal    skilled    solution    caused    7000    reducing    facilities    cross    66    positive    medical    improper    competitors    strategy    cagr    reg    customer    20    sterilize    time    amongst    innovative    100    eur    completely    nosocomial    world    cut    risks    care    individuals    worldwide    investigation    incorrect    axvirium    occupational    nearly    degradation    billion    structures    200    bioactive    accounted    economic    plus    waste    16    decreasing    reduce   

Project "ABT" data sheet

The following table provides information about the project.

Coordinator		 ENPROJECT MEDICALI SRL 

Organization address
address: VIALE CARLO FAINA 30
city: MARSCIANO
postcode: 6055
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Italy [IT]
 Project website https://www.enprojectmedicali.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-02-01   to  2019-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ENPROJECT MEDICALI SRL IT (MARSCIANO) coordinator 50˙000.00

Map

 Project objective

The aim of the project is to validate the technical and economic feasibility of AXVIRIUM BIOACTIVE TECNOLOGY (ABT) an innovative biomedical device, based on the Adantium® Plus and Axivirium BIOACTIVE® molecules, enable to cut biological risks, improve efficiency and reduce cost of health care biomedical fluids disposal. Medical waste is posing a growing problem worldwide resulting in nearly 7000 tons every day of infectious /hazardous medical waste and 10 billion euro annually in disposal cost across the European health care industry. According to the World Health Organisation (WHO), incorrect and improper management of healthcare biological fluids can have direct impacts on the community, individuals working in health care facilities, and the natural environment. It estimated that at world level accidents caused by not proper biological risks management accounted for 66,000 cases of infection with the hepatitis B virus, 16,000 cases of infection with hepatitis C virus and 200 to 5,000 cases of HIV infection amongst the personnel of health-care facilities. Compared to competitors ABT is the unique solution able to reach 100% degradation of RNases almost in real time and completely sterilize biological fluids. This imply saving operational cost up to 20%, decreasing occupational diseases by 39% and reducing cross- nosocomial infection by 14%. In 2018, the valuation of the global fluid management market was EUR 10 billion and is anticipated to reach EUR 18 billion by 2022, at a positive CAGR of 4.8% in the next three years. The estimated market potential for ABT is about 21 million euro and we estimate to hire 23 high skilled employees. The feasibility study comprises an investigation of market structures, segments and barriers, a customer survey and product validation, the identification of key commercial partners and the development of an IP strategy.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ABT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ABT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

VINOQUANT11SUPERPLUS (2019)

A digital based system for measuring, showing and regulation of the complexe system of wine feremtation with high precision via a Bluetooth -Refractometer, a Software and a Bluetooth Thermostat

Read More  

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More